Table 2.
Summary of the advantages and disadvantages of therapeutic HPV DNA vaccines
Advantage | Attribute of therapeutic HPV DNA vaccines |
---|---|
Design | • Generates effective CTL and antibody responses |
• Can express tumor antigenic peptides | |
• Prolonged antigen expression increases the chances of developing immunologic memory | |
• Expressed antigens are subjected to the same glycosylation and post-translational modifications as natural viral infections | |
Safety | • Will not revert to virulent form |
• Does not contain actual infectious agents | |
• Repeated administration is safe and effective | |
• Clinical trials have not shown adverse events | |
Stability | • Temperature-stable |
• Long shelf life | |
Manufacture | • High purity large scale production |
• Rapid production and formulation | |
• Easy to store and transport |
Disadvantage | Attribute |
---|---|
Specificity | • Low transfection efficiency |
• Low immunogenicity | |
• DNA is unable to amplify or spread intercellularly | |
• Not specifically targeted to APCs | |
Body reaction | • Possibility for immune responses generated against DNA |
• Risk of genomic integration |
APCs, antigen-presenting cells; CTL, cytotoxic T lymphocyte.